BioCryst Pharmaceuticals Investor Relations Material
Latest events
M&A Announcement
BioCryst Pharmaceuticals
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from BioCryst Pharmaceuticals Inc
Access all reports
BioCryst Pharmaceuticals Inc develops and commercializes oral medications for rare and serious diseases. The company focuses on small-molecule therapeutics, including treatments for hereditary angioedema and viral infections. Its research pipeline supports expansion into additional indications. The company is headquartered in Durham, North Carolina, and its shares are listed on the NASDAQ.
Key slides for BioCryst Pharmaceuticals Inc
Q2 2024
BioCryst Pharmaceuticals Inc
Q4 2024
BioCryst Pharmaceuticals Inc
Latest articles
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
Ticker symbol
BCRX
Country
🇺🇸 United States